Literature DB >> 19463788

Critical role of Kupffer cells in the management of diet-induced diabetes and obesity.

Audrey M Neyrinck1, Patrice D Cani, Evelyne M Dewulf, Fabienne De Backer, Laure B Bindels, Nathalie M Delzenne.   

Abstract

The aim of this study was to investigate the role of Kupffer cell in glucose metabolism and hepatic insulin sensitivity in mice. Both phagocytic activity and secretory capacity of Kupffer cells were blunted 24h after GdCl3 administration. Glucose tolerance--evaluated following an oral glucose tolerance test (OGTT)--was higher in GdCl3-treated mice whereas fasting insulinemia and HOMA-IR index decreased. The improvement of glucose tolerance and hepatic insulin signalling pathway after inhibition of Kupffer cells was supported by a lower hepatic gluconeogenic enzyme expression and a higher phosphorylation of Akt upon insulin challenge. Moreover, fasting hyperglycemia, insulin resistance and impaired glucose tolerance--induced by high fat (HF) diet--were improved through chronic administration of GdCl3. Interestingly, the inhibition of Kupffer cell exerted antiobesity effects in HF-fed mice, and lowered hepatic steatosis. Therefore, strategies targeting Kupffer cell functions could be a promising approach to counteract obesity and related metabolic disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19463788     DOI: 10.1016/j.bbrc.2009.05.070

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  47 in total

Review 1.  Alternative macrophage activation and metabolism.

Authors:  Justin I Odegaard; Ajay Chawla
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

Review 2.  Liver macrophages in healthy and diseased liver.

Authors:  Zeinab Abdullah; Percy A Knolle
Journal:  Pflugers Arch       Date:  2017-03-14       Impact factor: 3.657

Review 3.  Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.

Authors:  Julio Plaza-Diaz; Carolina Gomez-Llorente; Luis Fontana; Angel Gil
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 4.  The cellular and signaling networks linking the immune system and metabolism in disease.

Authors:  Olivia Osborn; Jerrold M Olefsky
Journal:  Nat Med       Date:  2012-03-06       Impact factor: 53.440

5.  Modulation of hepatocyte sialylation drives spontaneous fatty liver disease and inflammation.

Authors:  Douglas M Oswald; Mark B Jones; Brian A Cobb
Journal:  Glycobiology       Date:  2020-04-20       Impact factor: 4.313

Review 6.  Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages.

Authors:  Lucía Fuentes; Tamás Roszer; Mercedes Ricote
Journal:  Mediators Inflamm       Date:  2010-05-20       Impact factor: 4.711

Review 7.  Fructose and cardiometabolic disorders: the controversy will, and must, continue.

Authors:  Nicolas Wiernsperger; Alain Geloen; Jean-Robert Rapin
Journal:  Clinics (Sao Paulo)       Date:  2010-07       Impact factor: 2.365

Review 8.  Breaking patterns of environmentally influenced disease for health risk reduction: immune perspectives.

Authors:  Rodney R Dietert; Jamie C DeWitt; Dori R Germolec; Judith T Zelikoff
Journal:  Environ Health Perspect       Date:  2010-05-18       Impact factor: 9.031

Review 9.  Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader
Journal:  Diabetes Care       Date:  2010-10       Impact factor: 19.112

10.  Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling.

Authors:  Alicia H Clementi; Allison M Gaudy; Nico van Rooijen; Robert H Pierce; Robert A Mooney
Journal:  Biochim Biophys Acta       Date:  2009-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.